Regulating Genome-Edited Products – an International Trade Law Perspective

Kim, Daria; Adekola, Tolulope Anthony; Endrich-Laimböck, Tobias; Hofmeister, Elisabeth

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Paper

Regulating Genome-Edited Products – an International Trade Law Perspective

MPS-Authors

/persons/resource/persons205923

Kim, Daria
MPI for Innovation and Competition, Max Planck Society;

/persons/resource/persons213886

Endrich-Laimböck, Tobias
MPI for Innovation and Competition, Max Planck Society;

/persons/resource/persons273862

Hofmeister, Elisabeth
MPI for Innovation and Competition, Max Planck Society;

External Resource

https://ssrn.com/abstract=4988104
(Preprint)

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Kim, D., Adekola, T. A., Endrich-Laimböck, T., & Hofmeister, E. (2024). Regulating Genome-Edited Products – an International Trade Law Perspective. Max Planck Institute for Innovation & Competition Research Paper, No. 24-13.

Cite as: https://hdl.handle.net/21.11116/0000-000F-F090-E

Abstract

This paper provides a preliminary assessment of the compliance of national marketing regulation concerning genome-edited food products with international trade law. It presents an overview of global regulatory trends in this area and focuses on the compatibility of the diverging regulatory approaches with World Trade Organization (WTO) law, particularly the Agreement on Sanitary and Phytosanitary Measures (SPS) and the Agreement on Technical Barriers to Trade (TBT). Overall, the analysis finds significant potential for trade concerns under WTO law. As consumer choice is becoming the primary justification for labelling requirements, the focus of the assessment of NGT related measures will likely shift towards the TBT Agreement.